Terumo has prevailed in a patent spat with Vascular Solutions, and the latter company will stop manufacturing and selling a device Terumo said infringed on its intellectual property.
BSD Medical inked a wide-ranging deal with Japanese med tech giant Terumo to distribute one of its signature tumor ablation devices in Europe, Western Asia and North Africa.
Terumo's drug-eluting stent, Nobori, nabbed a bit of Abbott Laboratories' Xience glory as it proved in a large study to be just as effective as the top-selling American brand.
The American College of Cardiology's annual scientific summit made for a busy weekend in the medical device world. We've rounded up some highlights from the annual expo.
Terumo is striking out on its own in the urology market, announcing that it will terminate its distribution deal with Boston Scientific and take on U.S. sales of its Glidewire Hydrophilic Guidewire products.
Switzerland's Biosensors International will work with Japan's Terumo to promote that company's Nobori drug-eluting stent in Japan.
Japanese device maker Terumo has extended a crucial licensing deal through 2014, an agreement that will be important for the company's drug-eluting stent sales in global markets.
Japan's Olympus ($OCPNY)--an endoscope giant also known for its cameras--is facing problems on multiple fronts today.
Japanese devicemaker Terumo is proposing a merger with Olympus, following similar moves by Sony and Fujifilm, The Wall Street Journal and Bloomberg are reporting.
A U.S. unit of Tokyo-based Terumo has agreed to the terms of a consent decree with the FDA regarding quality system improvements at an Ann Arbor, MI facility. Terumo Cardiovascular Systems also has